Skip to main content
Equibles

RENAISSANCE TECHNOLOGIES LLC

Position in VIR — Vir Biotechnology, Inc.

CIK 1037389 NEW YORK, NY
Back to VIR Full portfolio

Position in VIR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$10,361,844
+$3,540,023 QoQ
Shares Held
1,016,864
+33.6% QoQ
Ownership
0.601%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#26
of 237 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VIR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. VIR ranks #48 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EXEL
Exelixis, Inc.
 13,427,993 $730,617,099
2 CORT
Corcept Therapeutics Inc
 5,261,628 $457,498,554
3 INCY
Incyte Corp
 3,512,132 $398,135,283
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 320,008 $158,957,573
5 JAZZ
Jazz Pharmaceuticals plc
 562,073 $135,442,730
6 RPRX
Royalty Pharma plc
 1,935,800 $108,540,306
7 TVTX
Travere Therapeutics, Inc.
 1,833,079 $104,137,217
8 GMAB
Genmab A/S
 3,517,850 $96,635,339

All Filings in VIR

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,361,844 1,016,864
2026-03-31 $6,821,821 761,364
2025-12-31 $3,705,217 614,464
2025-09-30 $6,664,141 1,167,100
2025-06-30 $5,365,080 1,064,500
2025-03-31 $7,260,192 1,120,400
2024-12-31 $9,083,984 1,237,600
2024-09-30 $8,855,427 1,182,300
2024-06-30 $11,834,330 1,329,700
2024-03-31 $13,737,293 1,356,100
2023-12-31 $13,023,676 1,294,600
2023-09-30 $12,690,728 1,354,400
2023-06-30 $28,653,493 1,168,100
2023-03-31 $27,004,835 1,160,500
2022-12-31 $26,788,104 1,058,400
2022-09-30 $29,160,884 1,512,494
2022-06-30 $14,324,328 562,400
2022-03-31 $2,427,968 94,400
2021-12-31 $2,424,273 57,900
2021-06-30 $3,787,222 80,102
2020-03-31 $2,004,795 58,500